Lantern Pharma Files 8-K with Exhibits
Ticker: LTRN · Form: 8-K · Filed: Apr 10, 2026 · CIK: 0001763950
| Field | Detail |
|---|---|
| Company | Lantern Pharma Inc. (LTRN) |
| Form Type | 8-K |
| Filed Date | Apr 10, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd, filing
TL;DR
Lantern Pharma dropped an 8-K, likely with new info. Check the exhibits.
AI Summary
Lantern Pharma Inc. filed an 8-K on April 10, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The filing includes various exhibits, such as the 8-K form itself and supplemental graphical information, indicating a disclosure event on April 9, 2026.
Why It Matters
This 8-K filing signals a material event or disclosure by Lantern Pharma, requiring immediate public notification to investors.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can significantly impact a company's stock price, necessitating careful review.
Key Numbers
- 0001763950 — CIK Number (Identifies Lantern Pharma Inc. in SEC filings.)
- 0001493152-26-016047 — SEC Accession Number (Unique identifier for this specific 8-K filing.)
Key Players & Entities
- Lantern Pharma Inc. (company) — Filer of the 8-K
- 0001763950 (company) — CIK number for Lantern Pharma Inc.
- 2026-04-10 (date) — Filing date of the 8-K
- 2026-04-09 (date) — Period of report for the 8-K
FAQ
What specific information is disclosed under Regulation FD?
The filing does not detail the specific information disclosed under Item 7.01 (Regulation FD Disclosure), but it is presented as an exhibit (EX-99.1).
What is the purpose of the graphical exhibits (EX-99.1_001.jpg to EX-99.1_008.jpg)?
These graphical exhibits are part of the supplemental information provided with the 8-K filing, likely to visually represent data or findings related to the disclosure.
When was the period of report for this 8-K filing?
The period of report for this 8-K filing was April 9, 2026.
What are the mailing and business addresses for Lantern Pharma Inc.?
The mailing and business addresses for Lantern Pharma Inc. are both listed as 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201.
What SIC code is associated with Lantern Pharma Inc.?
The SIC code associated with Lantern Pharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 10, 2026 regarding Lantern Pharma Inc. (LTRN).